AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimbite-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Pure and Cure Healthcare Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimbite-M1 Tablet PR

DiabetaComb PR tablets are classified as antidiabetic medications, a dual-drug formulation for adult type 2 diabetes management. This medication helps regulate blood sugar. DiabetaComb PR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimbite-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimbite-M1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Take Glimbite-M1 Tablet PR with a meal.

Common Side effects of Glimbite-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimbite-M1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Take Glimbite-M1 Tablet PR with meals.

How Glimbite-M1 Tablet PR works:

Glimbite-M1 PR tablets contain a dual-action formulation of glimepiride and metformin, both effective in managing diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimbite-M1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimbite-M1 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Nursing mothers should avoid Glimbite-M1 Tablet PR; evidence indicates potential infant harm from the medication's toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Glimbite-M1 Tablet PR to individuals with kidney impairment; dosage modification may be necessary. Consult a physician before use. Glimbite-M1 Tablet PR is contraindicated in patients exhibiting severe kidney dysfunction. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when administering Glimbite-M1 Tablet PR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. A reduced initial dose of Glimbite-M1 Tablet PR is typically prescribed for patients exhibiting mild to moderate liver dysfunction; its use is contraindicated in those with severe liver disease.

What if you forget to take Glimbite-M1 Tablet PR :

Should you forget a Glimbite-M1 Tablet PR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimbite-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimbite-M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimbite-M1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimbite-M1 Tablet PR and seek immediate medical attention.
Glimbite-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Glimbite-M1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimbite-M1 Tablet PR use can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimbite-M1 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimbite-M1 Tablet PR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimbite-M1 Tablet PR
89
MRP 109
18% off